… , metastatic hormone-sensitive prostate cancer (mHSPC) treated with … diagnosed with prostate cancer never die of prostate cancer, depending … when determining whether docetaxel is better first … -metastatic-hormone-sensitive-prostate-cancer FDA expands Pluvicto …

… some recent advancements in prostate cancer that you think clinicians … of treatment for metastatic prostate cancer, but adding antiandrogens upfront … I helped to get docetaxel approved, it was pretty … more targeted therapies for prostate cancer. We have the …

… in mouse prostate cancer models, docetaxel-loaded microspheres … prostate cancer tissues. The significant heterogeneity of prostate cancer … Castration-Resistant Prostate Cancer: Multicohort, … for Prostate Cancer: a systematic review. Prostate Cancer Prostatic …

… recognition of September as Prostate Cancer Awareness Month, Daniel Petrylak … oncology, especially in prostate cancer, is the proper … . For example, when docetaxel was approved, it was … for various stages of prostate cancer, often with overlapping indications …

… in treating metastatic hormone-sensitive prostate cancer (mHSPC). Tian Zhang, … with metastatic hormone sensitive prostate cancer. If they had received … them they need ADT, docetaxel, and an oral … with metastatic hormone-sensitive prostate cancer from the phase …

… prostate cancer growth and expressed in around 90% of prostate cancers, … docetaxel versus docetaxel for previously treated metastatic castration-resistant prostate cancer: … metastatic prostate cancer and PI3K pathway alterations. Prostate Cancer Prostatic …

… 177 vipivotide tetraxetan (Pluvicto) and docetaxel for the treatment of patients … (PSMA)–positive metastatic castration-resistant prostate cancer (mCRPC) after prior treatment with … when and if patients receive docetaxel with lutetium Lu 177 vipivotide …

… for patients with metastatic prostate cancer. The study involved … high-risk or metastatic prostate cancer who were randomized … 832 patients with metastatic prostate cancer, those with higher … from the addition of docetaxel, suggesting potential opportunities …

… improving castration-resistant prostate cancer-free survival. Furthermore … several malignancies, including prostate cancer, and to … radiation therapy, docetaxel or androgen receptor … patients with metastatic prostate cancer starting androgen deprivation …

… -resistant prostate cancer (mCRPC) whose disease has progressed on or after docetaxel therapy … -resistant prostate cancer (mCRPC) whose disease has progressed on or after docetaxel therapy …